BWP
BSX icon

Baldwin Wealth Partners’s Boston Scientific BSX Stock Holding History

Baldwin Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$41.9K – 336
2024
Q3 		$41.9K Sell
500
-12
-2% -$946 ﹤0.01% 582
2024
Q2 		$39.4K Sell
512
-88
-15% -$6.44K ﹤0.01% 381
2024
Q1 		$41.1K Hold
600
– – ﹤0.01% 391
2023
Q4 		$34.7K Hold
600
– – ﹤0.01% 426
2023
Q3 		$31.7K Hold
600
– – ﹤0.01% 450
2023
Q2 		$32.5K Hold
600
– – ﹤0.01% 468
2023
Q1 		$30K Sell
600
-137
-19% -$6.46K ﹤0.01% 500
2022
Q4 		$34.1K Buy
+737
New +$31.9K ﹤0.01% 468

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baldwin Wealth Partners's BSX Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 500 shares — an estimated $41.9K sold.

Baldwin Wealth Partners first reported a position in BSX in Q4 2022 and held it in 8 quarters. The position peaked at $41.9K in Q3 2024. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 500 Boston Scientific shares in Q4 2024, an estimated $41.9K.
  • Baldwin Wealth Partners first reported a position in Boston Scientific in Q4 2022 and held it in 8 quarters.
  • Baldwin Wealth Partners's Boston Scientific position peaked at $41.9K in Q3 2024.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.